Genmab A/S (GMAB) — Cash Flow Quality Index
Genmab A/S (GMAB) has a Cash Flow Quality Index of 1.11x as of September 2025. Operating cash flow of Dkr536.00 Million exceeds net income of Dkr482.00 Million, indicating high earnings quality where cash backs reported profits. Explore Genmab A/S cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Genmab A/S Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Genmab A/S across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Genmab A/S to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Genmab A/S (2013–2024)
Year-by-year earnings quality comparison for Genmab A/S. For live market cap and the full company financial profile, see Genmab A/S market cap and net worth.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | Dkr7.77 Billion | Dkr7.84 Billion | ▼ -24.3% |
| 2023 | 1.31x | Dkr7.38 Billion | Dkr5.64 Billion | ▲ +135.4% |
| 2022 | 0.56x | Dkr3.91 Billion | Dkr7.04 Billion | ▼ -0.6% |
| 2021 | 0.56x | Dkr2.23 Billion | Dkr3.98 Billion | ▼ -48.7% |
| 2020 | 1.09x | Dkr6.43 Billion | Dkr5.90 Billion | ▲ +134.9% |
| 2019 | 0.46x | Dkr1.33 Billion | Dkr2.86 Billion | ▼ -26.3% |
| 2018 | 0.63x | Dkr1.01 Billion | Dkr1.61 Billion | ▼ -57.9% |
| 2017 | 1.49x | Dkr1.59 Billion | Dkr1.06 Billion | ▲ +415.2% |
| 2016 | 0.29x | Dkr327.72 Million | Dkr1.13 Billion | ▼ -29.5% |
| 2015 | 0.41x | Dkr311.45 Million | Dkr757.53 Million | ▼ -7.9% |
| 2014 | 0.45x | Dkr132.67 Million | Dkr297.35 Million | ▲ +137.5% |
| 2013 | -1.19x | Dkr-128.00 Million | Dkr107.64 Million | — |